Pilocarpine is a medication used to treat dryness of the mouth and throat (xerostomia) caused by reduced saliva production, which may occur after radiation therapy for head and neck cancer or in individuals with Sjögren's syndrome. Pilocarpine is a cholinergic agent that works by stimulating the muscarinic receptors, increasing the production of saliva and other secretions.
In addition to its use in treating xerostomia, pilocarpine is also used in ophthalmology to reduce intraocular pressure in conditions like glaucoma.
Parent: Pilocarpine
Parent: Pilocarpine
Parent: Pilocarpine
Parent: Pilocarpine
Parent: Pilocarpine
Parent: Pilocarpine Nitrate / Pilocarpine
Parent: Pilocarpine
Parent: Pilocarpine
Parent: Pilocarpine
As with all pharmaceutical products, impurities may develop in pilocarpine during its manufacturing, storage, or handling. Regulatory authorities enforce stringent guidelines to monitor and control these impurities, ensuring the medication’s safety, efficacy, and quality.
Related Substances
These are chemically related compounds or byproducts formed during the synthesis of pilocarpine. Monitoring these related substances ensures the drug’s purity and therapeutic effectiveness.
Degradation Products
Pilocarpine is sensitive to environmental factors such as light, heat, and moisture, which can lead to degradation over time. Proper storage conditions are critical to minimize degradation and maintain its stability.
Residual Solvents
Trace amounts of solvents used during manufacturing may remain in the final product. Regulatory standards ensure these solvents are within permissible limits to reduce risks to patients.
Analytical Techniques for Monitoring Impurities
Techniques such as High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (LC-MS) are commonly employed to detect and quantify impurities, ensuring pilocarpine meets stringent safety and quality standards.
Pilocarpine stimulates the muscarinic receptors, increasing the production of saliva and other secretions. It is used to treat dry mouth caused by radiation therapy or Sjögren’s syndrome. It is also used to lower intraocular pressure in glaucoma.
Pilocarpine is a cholinergic agent. It acts as a muscarinic receptor agonist, mimicking the effects of acetylcholine to stimulate glandular secretions.
Pilocarpine binds to muscarinic receptors, particularly M3 receptors, in salivary glands and other tissues. This action stimulates the secretion of saliva, tears, and other bodily fluids, providing relief from dryness. In the eye, it constricts the pupil and opens the drainage angle, reducing intraocular pressure.
The antidote for pilocarpine overdose is atropine, an anticholinergic agent. Atropine works by blocking muscarinic receptors, counteracting the effects of excessive cholinergic stimulation caused by pilocarpine.
